Pulse Biosciences, Inc. (PLSE)

Market Cap	991.65M
Revenue (ttm)	n/a
Net Income (ttm)	-46.13M
Shares Out	61.52M
EPS (ttm)	-0.83
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,004
Open	16.04
Previous Close	16.14
Day's Range	15.67 - 16.53
52-Week Range	6.60 - 22.69
Beta	1.75
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About PLSE

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. The company offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporat...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 18, 2016
• Employees: 56
• Stock Exchange: NASDAQ
• Ticker Symbol: PLSE
• Website: https://www.pulsebiosciences.com